Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Sopik

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|July 9, 2016
A model for ovarian cancer progression based on inherent resistanceVasily Giannakeas, Victoria Sopik, Steven A Narod
Breast Cancer Research and Treatment|November 10, 2017
Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situVictoria Sopik, Ping Sun, Steven A Narod
Gynecologic Oncology|February 27, 2016
Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trialSteven A Narod, Victoria Sopik, Vasily Giannakeas
Breast Cancer Research and Treatment|April 5, 2017
Which women decide to take tamoxifen?Steven A Narod, Victoria Sopik, Ping Sun
Breast Cancer Research and Treatment|June 12, 2017
The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patientsVictoria Sopik, Ping Sun, Steven A Narod
Current Oncology (Toronto, Ont.)|May 15, 2023
Prognosis after Local Recurrence in Patients with Early-Stage Breast Cancer Treated without ChemotherapyVictoria Sopik, David Lim, Ping Sun, et al.
Gynecologic Oncology|June 17, 2015
Why have ovarian cancer mortality rates declined? Part I. IncidenceVictoria Sopik, Javaid Iqbal, Barry Rosen, et al.
Gynecologic Oncology|June 17, 2015
Why have ovarian cancer mortality rates declined? Part II. Case-fatalityVictoria Sopik, Javaid Iqbal, Barry Rosen, et al.
Gynecologic Oncology|June 19, 2015
Why have ovarian cancer mortality rates declined? Part III. Prospects for the futureVictoria Sopik, Barry Rosen, Vasily Giannakeas, et al.
Breast Cancer Research and Treatment|July 8, 2016
Impact of a prior diagnosis of DCIS on survival from invasive breast cancerVictoria Sopik, Javaid Iqbal, Ping Sun, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|July 9, 2016
A model for ovarian cancer progression based on inherent resistanceVasily Giannakeas, Victoria Sopik, Steven A Narod
Breast Cancer Research and Treatment|November 10, 2017
Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situVictoria Sopik, Ping Sun, Steven A Narod
Gynecologic Oncology|February 27, 2016
Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trialSteven A Narod, Victoria Sopik, Vasily Giannakeas
Breast Cancer Research and Treatment|April 5, 2017
Which women decide to take tamoxifen?Steven A Narod, Victoria Sopik, Ping Sun
Breast Cancer Research and Treatment|June 12, 2017
The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patientsVictoria Sopik, Ping Sun, Steven A Narod
Current Oncology (Toronto, Ont.)|May 15, 2023
Prognosis after Local Recurrence in Patients with Early-Stage Breast Cancer Treated without ChemotherapyVictoria Sopik, David Lim, Ping Sun, et al.
Gynecologic Oncology|June 17, 2015
Why have ovarian cancer mortality rates declined? Part I. IncidenceVictoria Sopik, Javaid Iqbal, Barry Rosen, et al.
Gynecologic Oncology|June 17, 2015
Why have ovarian cancer mortality rates declined? Part II. Case-fatalityVictoria Sopik, Javaid Iqbal, Barry Rosen, et al.
Gynecologic Oncology|June 19, 2015
Why have ovarian cancer mortality rates declined? Part III. Prospects for the futureVictoria Sopik, Barry Rosen, Vasily Giannakeas, et al.
Breast Cancer Research and Treatment|July 8, 2016
Impact of a prior diagnosis of DCIS on survival from invasive breast cancerVictoria Sopik, Javaid Iqbal, Ping Sun, et al.
Pageof 5